Q-omics provides the consensus-scored MIR876 profile across patient tissues and cancer cell-line models. MIR876 expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, MIR876 RNA expression shows 8,163 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight STAD, and GBM as cancer lineages where MIR876 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.